133 related articles for article (PubMed ID: 38155082)
1. Remission of organ failure in patients with predicted severe acute pancreatitis treated by somatostation, octreotide and cyclooxygenase-2 inhibitors.
Huang ZY; Gong H; Tang CW; Wang MJ; Wang R
Pancreatology; 2024 Feb; 24(1):24-31. PubMed ID: 38155082
[TBL] [Abstract][Full Text] [Related]
2. High-dose versus low-dose octreotide in the treatment of acute pancreatitis: a randomized controlled trial.
Wang R; Yang F; Wu H; Wang Y; Huang Z; Hu B; Zhang M; Tang C
Peptides; 2013 Feb; 40():57-64. PubMed ID: 23275042
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Severe Acute Pancreatitis With Cyclooxygenase-2 Inhibitors: A Randomized Controlled Clinical Trial.
Huang Z; Ma X; Jia X; Wang R; Liu L; Zhang M; Wan X; Tang C; Huang L
Am J Gastroenterol; 2020 Mar; 115(3):473-480. PubMed ID: 32142484
[TBL] [Abstract][Full Text] [Related]
4. Prevention of severe acute pancreatitis with octreotide in obese patients: a prospective multi-center randomized controlled trial.
Yang F; Wu H; Li Y; Li Z; Wang C; Yang J; Hu B; Huang Z; Ji R; Zhan X; Xie H; Wang L; Zhang M; Tang C
Pancreas; 2012 Nov; 41(8):1206-12. PubMed ID: 23086244
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
[TBL] [Abstract][Full Text] [Related]
6. Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study.
Sun C; Li Z; Shi Z; Li G
BMC Gastroenterol; 2021 May; 21(1):210. PubMed ID: 33964868
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of baicalin and octreotide on multiple organ injury in severe acute pancreatitis.
Zhang XP; Zhang L; Yang P; Zhang RP; Cheng QH
Dig Dis Sci; 2008 Feb; 53(2):581-91. PubMed ID: 17549629
[TBL] [Abstract][Full Text] [Related]
8. Intestinal bacterial overgrowth in the early stage of severe acute pancreatitis is associated with acute respiratory distress syndrome.
Liang XY; Jia TX; Zhang M
World J Gastroenterol; 2021 Apr; 27(15):1643-1654. PubMed ID: 33958849
[TBL] [Abstract][Full Text] [Related]
9. AGI grade-guided chaiqin chengqi decoction treatment for predicted moderately severe and severe acute pancreatitis (CAP trial): study protocol of a randomised, double-blind, placebo-controlled, parallel-group, pragmatic clinical trial.
Chen Z; Yang X; Guo J; Jin T; Lin Z; Zhu P; Li J; Li L; Sun X; Du D; Jiang K; He Y; Cai F; Li L; Hu C; Tan Q; Huang W; Deng L; Xia Q
Trials; 2022 Nov; 23(1):933. PubMed ID: 36348365
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of abdominal hemorrhage in patients with severe acute pancreatitis and its influence on outcomes].
Fu B; Fan Z; Gao F; Su D; Hu J; Geng Z; Fu X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):70-74. PubMed ID: 35307064
[TBL] [Abstract][Full Text] [Related]
11. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.
Büchler MW; Binder M; Friess H
Gut; 1994; 35(3 Suppl):S15-9. PubMed ID: 7911442
[TBL] [Abstract][Full Text] [Related]
12. Caspase-1 inhibition alleviates acute renal injury in rats with severe acute pancreatitis.
Zhang XH; Li ML; Wang B; Guo MX; Zhu RM
World J Gastroenterol; 2014 Aug; 20(30):10457-63. PubMed ID: 25132762
[TBL] [Abstract][Full Text] [Related]
13. Formalized therapeutic guideline for hyperlipidemic severe acute pancreatitis.
Mao EQ; Tang YQ; Zhang SD
World J Gastroenterol; 2003 Nov; 9(11):2622-6. PubMed ID: 14606112
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of severe acute pancreatitis.
Kong L; Santiago N; Han TQ; Zhang SD
World J Gastroenterol; 2004 Nov; 10(22):3336-8. PubMed ID: 15484312
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of caspase-1 inhibitors on acute lung injury in experimental severe acute pancreatitis.
Zhang XH; Zhu RM; Xu WA; Wan HJ; Lu H
World J Gastroenterol; 2007 Jan; 13(4):623-7. PubMed ID: 17278232
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis.
Omata F; Deshpande G; Tokuda Y; Takahashi O; Ohde S; Carr-Locke DL; Jacobs JL; Mine T; Fukui T
J Gastroenterol; 2010 Aug; 45(8):885-95. PubMed ID: 20373114
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades.
Li J; Wang R; Tang C
Curr Pharm Des; 2011; 17(16):1594-601. PubMed ID: 21548873
[TBL] [Abstract][Full Text] [Related]
18. Potential role of somatostatin and octreotide in the management of acute pancreatitis.
Büchler MW; Binder M; Friess H; Malfertheiner P
Digestion; 1994; 55 Suppl 1():16-9. PubMed ID: 7907565
[TBL] [Abstract][Full Text] [Related]
19. Conservative treatment of acute pancreatitis: the use of somatostatin.
Ladas SD; Raptis SA
Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
[TBL] [Abstract][Full Text] [Related]
20. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
Poon RT; Fan ST
JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
